(Philadelphia,
PA) - Robert G. Kalb, MD, has been named Associate
Professor in the Department of Neurology at the University
of Pennsylvania School of Medicine.
Dr. Kalb earned his BA degree in Biology from Wesleyan
University and his MD from Cornell University Medical
College. He performed his internship and residency in
Medicine at Montefiore Hospital in the Bronx, New York.
He completed a second residency, in Neurology, at Yale-New
Haven Hospital in Connecticut and a fellowship in the
Department of Neurobiology at Yale University.
Dr. Kalb's laboratory studies the molecular mechanisms
by which precise connections form between neurons during
development. His lab also studies why motor neurons
are vulnerable to insult, in relation to Lou Gehrig's
Disease.
He is a member of the American Association for the Advancement
of Science, the American Neurologic Association, the
Society for Neuroscience, and the American Academy of
Neurology. Among his many accolades, Dr. Kalb has received
the 2001 National Aeronautics and Space Administration
(NASA) Group Achievement Award from the Neurolab Spacelab
Mission Science Team, and the 2002 Decade of Service
Award-Teaching and Guidance, from Yale University.
Dr. Kalb is an ad-hoc reviewer for Neuron, Journal
of Neuroscience, Proceedings of the National Academy
of Science, European Journal of Neuroscience, Experimental
Brain Research, Brain Research and the Journal
of Neurobiology, among others. He has been invited
to lecture on several occasions, most recently at Yale
University on the topic, "The role of trophic factors
in excitotoxic motor neuron death." He has authored
or co-authored research in peer and non-peer reviewed
publications including Neuroscience, Neuron, the
Journal of Neuroscience, Annals of Neurology, Nature,
the Journal of Neurochemistry and Annals of
the New York Academy of Science.
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.